| Tretinoin | Approved Investigational Nutraceutical | HLA-G | 3135 |
upregulated | Tretinoin results in increased expression of HLA-G mRNA | 6p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HLA-J | 3137 |
upregulated | Tretinoin results in increased expression of HLA-J mRNA | 6p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HMGB2 | 3148 |
downregulated | Tretinoin results in decreased expression of HMGB2 mRNA | 4q34.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HMGCL | 3155 |
upregulated | Tretinoin results in increased expression of HMGCL mRNA | 1p36.11 | |
| Tretinoin | Approved Investigational Nutraceutical | HMGCS1 | 3157 |
downregulated | Tretinoin results in decreased expression of HMGCS1 mRNA | 5p12 | |
| Tretinoin | Approved Investigational Nutraceutical | HMGN3 | 9324 |
upregulated | Tretinoin results in increased expression of HMGN3 mRNA | 6q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HMOX1 | 3162 |
downregulated | Tretinoin results in decreased expression of HMOX1 mRNA | 22q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HMOX1 | 3162 |
upregulated | Tretinoin results in increased expression of HMOX1 mRNA | 22q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HNRNPA3P1 | 10151 |
downregulated | Tretinoin results in decreased expression of HNRNPA3P1 mRNA | 10q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | HNRNPC | 3183 |
downregulated | Tretinoin results in decreased expression of HNRNPC mRNA | 14q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HNRNPDL | 9987 |
upregulated | Tretinoin results in increased expression of HNRNPDL mRNA | 4q21.22 | |
| Tretinoin | Approved Investigational Nutraceutical | HNRNPU | 3192 |
upregulated | Tretinoin results in increased expression of HNRNPU mRNA | 1q44 | |
| Tretinoin | Approved Investigational Nutraceutical | HOOK1 | 51361 |
downregulated | Tretinoin results in decreased expression of HOOK1 mRNA | 1p32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HOPX | 84525 |
upregulated | Tretinoin results in increased expression of HOPX mRNA | 4q12 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXA1 | 3198 |
upregulated | Tretinoin results in increased expression of HOXA1 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXA10 | 3206 |
upregulated | Tretinoin results in increased expression of HOXA10 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXA2 | 3199 |
upregulated | Tretinoin results in increased expression of HOXA2 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXA3 | 3200 |
upregulated | Tretinoin results in increased expression of HOXA3 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXA4 | 3201 |
upregulated | Tretinoin results in increased expression of HOXA4 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXA5 | 3202 |
upregulated | Tretinoin results in increased expression of HOXA5 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXA6 | 3203 |
upregulated | Tretinoin results in increased expression of HOXA6 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXA7 | 3204 |
upregulated | Tretinoin results in increased expression of HOXA7 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXA9 | 3205 |
upregulated | Tretinoin results in increased expression of HOXA9 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXB1 | 3211 |
upregulated | Tretinoin results in increased expression of HOXB1 mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXB2 | 3212 |
upregulated | Tretinoin results in increased expression of HOXB2 mRNA | 17q21.32 | |